Adverse Events Associated with Risperidone Use in Pediatric Patients: A Retrospective Biobank Study.

ABSTRACT:

Background

Although risperidone is increasingly used for behavioral indications in children, the associated adverse events (AEs) are not well defined in this population.

Objective

We determined the incidence of and risk factors for AEs among children treated with risperidone at our institution, an academic medical center with inpatient, outpatient, generalist, and specialist pediatric care.

Methods

The study included children aged ≤ 18 years with ≥ 4 weeks of risperidone exposure. Data were obtained using de-identified electronic health records. AEs were defined as any untoward event attributed to risperidone reported by the patient, parent/guardian, or physician or detected following a laboratory investigation. Associations between AEs and clinical variables were det

SUBMITTER: Oshikoya KA 

PROVIDER: S-EPMC6520321 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature